CTXR Citius Pharmaceuticals Inc. Common PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

CTXR Stock Analysis: Buy, Sell, or Hold?

$0.49
-0.03 (-6.37%) β–Ό
5d: -14.03% 30d: +0.0% 90d: -35.58%
Open in Live Scanner Earnings: Dec 22, 2026 Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
33/100
Position
FAIR
30-Day Fair Range
$0.44 – $0.55
Position: FAIR
Forward P/E & Valuation
-0.3x CHEAP
vs 0.3x historical avg
Wall Street Target
$4.00
+711.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.48 / $0.65
Trend: Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CTXR is down 14.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When CTXR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CTXR is currently trading at $0.49, which is considered fair relative to its 30-day fair value range of $0.44 to $0.55. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.3) compared to its historical average (0.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CTXR is in a downtrend. Immediate support is located at $0.48, while resistance sits at $0.65. Short-term momentum is weak, with the stock down 6.4% recently.

Market Sentiment: CTXR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+711.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.44 - $0.55
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 50.0%

Trading Range & Key Levels

30-Day Trading Range $0.44 - $0.55
Current vs Trading Range FAIR
Support Level $0.48
Resistance Level $0.65
Current Trend Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (5/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.4%)
  • BULLISH: Trading 711.7% below Wall St target ($4.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 33/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.34
Wall Street Target $4.00 (+711.7%)
PE vs Historical -0.3 vs 0.3 CHEAP
Share CTXR Analysis

Share this live CTXR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CTXR)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 30, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits with one user expressing confidence in $CTXR.
Key Retail Themes: Bullish outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:14 PM ET
Data refreshes hourly during market hours. Next update: 11:14 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CTXR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 52 HOLD
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$84 45 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 42 HOLD
GPCR
Structure Therapeutics I…
STRONG BUY
16 analysts
$107 49 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CTXR Research Pages
CTXR Technical Chart CTXR Price Prediction CTXR Intrinsic Value DCF CTXR Earnings Date CTXR Investment Advisor CTXR Fair Price Analyzer CTXR Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals